[PDF] hexal ag - Pharmatrix

Who owns Hexal pharmaceuticals?

Hexal is led by cofounders and twin brothers Thomas and Andreas Strüngmann and remains a privately owned company. Hexal was founded by twin brothers Thomas and Andreas Strüngmann. The Strüngmann brothers were no strangers to pharmaceuticals: father Ernst Strüngmann had earlier founded the Frankfurt-based company Durachemie.

Who is Hexal Chemie?

Hexal Chemie GmbH & Co. KG, as the company was called, started off with five drug preparations and just 22 employees. Instead of producing copycat generics, Hexal recognized the market potential for developing new formulations and delivery methods of existing drugs.

What does Hexal do?

HEXAL offers cost-effective and high-quality medicinal products based on approx. 250 proven active substances. The comprehensive portfolio of OTC and prescription-only pharmaceuticals covers all major indications. 1979: Thomas Strüngmann joins his father's company, Durachemie, as CEO.

Does Novartis own Hexal?

We’ll send you a myFT Daily Digest email rounding up the latest Switzerland news every morning. Novartis on Monday bought privately owned Hexal of Germany for a total of $8.3bn of cash, in a deal that establishes it as the world's biggest maker of generic drugs and sets it apart from the rest of the pharmaceuticals industry.